Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections

Background: The limited armamentarium against multidrug-resistant Gram-negative bacilli led to the development of a new generation of β-lactam/β-lactamase inhibitor combinations (BL/BLI). Objectives: To evaluate the in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, meropenem/vaborb...

Full description

Saved in:
Bibliographic Details
Main Authors: Helio S. Sader, Mariana Castanheira, Leonard R. Duncan, Rodrigo E. Mendes
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
Online Access:https://doaj.org/article/bf9c27dc44894de6a4e64077bcd0288a
Tags: Add Tag
No Tags, Be the first to tag this record!